Abstract
Bone is a common site for metastases in patients with advanced breast or prostate cancer, with greater than 65% of patients developing bone metastases. This is hypothesized to be related to the bone marrow microenvironment providing a favorable niche for cancer cell survival and growth. Circulating tumor cells (CTCs) can colonize bone marrow niches to become disseminated tumor cells (DTCs). Survival of DTCs in the bone marrow is a function of the unique microenvironment and the ability of these cells to acquire an osteoblast-like phenotype through a process known as osteomimicry. Detecting CTCs in blood or DTCs in bone marrow has been shown to independently predict for disease progression and worse clinical outcomes in patients with breast or prostate cancer. Therapies that reduce levels of CTCs and DTCs may improve clinical outcomes in these patients. Bisphosphonates are bone-targeted agents used to reduce the rate of skeletal-related events in patients with bone metastases. Bisphosphonates such as zoledronic acid have demonstrated potential anticancer activity, and zoledronic acid was recently shown to reduce the persistence and prevalence of DTCs in patients with breast cancer. Research is ongoing to further define the role of bone-targeted therapies in the treatment of cancer.
Keywords: Bisphosphonates, breast cancer, circulating tumor cells, disseminated tumor cells, prostate cancer, zoledronic acid.
Current Cancer Therapy Reviews
Title:The Effects of Bisphosphonates on the Bone Marrow Niche and Circulating and Disseminated Tumor Cells
Volume: 9 Issue: 2
Author(s): Rebecca L. Aft
Affiliation:
Keywords: Bisphosphonates, breast cancer, circulating tumor cells, disseminated tumor cells, prostate cancer, zoledronic acid.
Abstract: Bone is a common site for metastases in patients with advanced breast or prostate cancer, with greater than 65% of patients developing bone metastases. This is hypothesized to be related to the bone marrow microenvironment providing a favorable niche for cancer cell survival and growth. Circulating tumor cells (CTCs) can colonize bone marrow niches to become disseminated tumor cells (DTCs). Survival of DTCs in the bone marrow is a function of the unique microenvironment and the ability of these cells to acquire an osteoblast-like phenotype through a process known as osteomimicry. Detecting CTCs in blood or DTCs in bone marrow has been shown to independently predict for disease progression and worse clinical outcomes in patients with breast or prostate cancer. Therapies that reduce levels of CTCs and DTCs may improve clinical outcomes in these patients. Bisphosphonates are bone-targeted agents used to reduce the rate of skeletal-related events in patients with bone metastases. Bisphosphonates such as zoledronic acid have demonstrated potential anticancer activity, and zoledronic acid was recently shown to reduce the persistence and prevalence of DTCs in patients with breast cancer. Research is ongoing to further define the role of bone-targeted therapies in the treatment of cancer.
Export Options
About this article
Cite this article as:
Aft L. Rebecca, The Effects of Bisphosphonates on the Bone Marrow Niche and Circulating and Disseminated Tumor Cells, Current Cancer Therapy Reviews 2013; 9 (2) . https://dx.doi.org/10.2174/1573394711309020001
DOI https://dx.doi.org/10.2174/1573394711309020001 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics
The thematic issue will focus on key areas such as lipid nanoparticles, mRNA therapeutics, drug delivery systems, nanotechnology in medicine, targeted therapy, non-viral vectors, precision medicine, and biomedical engineering.read more
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protease Inhibitors in the Clinic
Medicinal Chemistry The Challenge of Exploiting ABCG2 in the Clinic
Current Pharmaceutical Biotechnology The Role and Therapeutic Potential of Ser/Thr Phosphatase PP2A in Apoptotic Signalling Networks in Human Cancer Cells
Current Molecular Medicine Phytoestrogens: Implications in Neurovascular Research
Current Neurovascular Research Estrogen Receptor Polymorphisms: Significance to Human Physiology, Disease and Therapy
Recent Patents on DNA & Gene Sequences Chemical Synthesis, Characterisation and Biological Evaluation of Furanic- Estradiol Derivatives as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1
Medicinal Chemistry Cardiotoxicity of Tyrosine-Kinase-Targeting Drugs
Cardiovascular & Hematological Agents in Medicinal Chemistry The Extracapsular Lymph Node Extension Predicts Outcomes in Colorectal Cancer: A Short Review
Current Drug Targets Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
Current Drug Targets Review of Sacred Herbal Medicine <i>Aegle marmelos</i>: A Potent Metastasis Inhibitor
Current Functional Foods C-Methionine PET/CT in Central Nervous System Tumours: A Review
Current Radiopharmaceuticals Antimicrobial Resistance in the 21st Century: A Multifaceted Challenge
Protein & Peptide Letters Fullerenes for Applications in Biology and Medicine
Current Medicinal Chemistry Biochemical Properties of Indoleamine 2,3-dioxygenase: From Structure to Optimized Design of Inhibitors
Current Medicinal Chemistry Postmenopausal Osteoporosis and Aerobic Exercise: A Review of the Literature
Current Rheumatology Reviews MIF and CD74 - Suitability as Clinical Biomarkers
Mini-Reviews in Medicinal Chemistry Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies
Current Drug Delivery Resveratrol Counteracts Hypoxia-Induced Gastric Cancer Invasion and EMT through Hedgehog Pathway Suppression
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Ginsenosides as Potential Therapeutics Against Breast Cancer
Current Topics in Medicinal Chemistry